Loiasis: Clinical Trials

2 trials for Loiasis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Completed 2

Follow Loiasis: new trials by email Literature Review of Loiasis trials Research Report on Loiasis

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Loiasis Cross-reactive Antigenemia and Treatment-related Adverse Events
Ivermectin - Loiasis
Phase 4CompletedWashington University School of Medicine412021-07-302022-09-29
Post-treatment Effects of Ivermectin (IVM) or Diethylcarbamazine (DEC) in Loiasis
Diethylcarbamazine, Ivermectin - Loiasis
Phase 4CompletedNational Institute of Allergy and Infectious Diseases (NIAID)1552012-04-012016-11-09

Broader conditions

Filariasis (2)  ·  Helminthiasis (2)  ·  Infections (2)  ·  Nematode Infections (2)  ·  Parasitic Diseases (2)  ·  Secernentea Infections (2)  ·  Spirurida Infections (2)

Interventions

Ivermectin (2)  ·  Diethylcarbamazine (1)

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID) (1)  ·  Washington University School of Medicine (1)

Countries

Cameroon (2)

Top investigators

Amy D Klion, M.D. (1)

Results publications

PMID 28329346